Early development does not appear to be affected in children born to mothers who were treated with the antimalarial mefloquine during pregnancy compared to children of mothers treated with sulfadoxine-pyrimethamine, according to research.
Early development does not appear to be affected in children born to mothers who were treated with the antimalarial mefloquine during pregnancy compared to children of mothers treated with sulfadoxine-pyrimethamine, according to research.